- Issuer ticker
-
DSGN
- Reported as of
-
10 Jun 2025
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
12 Jun 2025, 16:30:24 UTC
Filing notes and source
Key filing fact
Deepa Prasad filed Form 4 for Design Therapeutics, Inc. (DSGN) on 12 Jun 2025.
Key facts
- This page summarizes Deepa Prasad's Form 4 filing for Design Therapeutics, Inc. (DSGN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 12 Jun 2025, 16:30.
Change
- Previous filing in this sequence was filed on 19 Dec 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001867165
Primary reporting owner
Prasad Deepa
- Relationship
-
Director
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DSGN
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +19,000
- Change %
- Price
-
$0.000000
- Shares after
- 19,000
- Date
- 10 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,000
- Exercise price
- $4.01
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote